Cancer comprises a heterogeneous group of diseases associated with substantial global mortality and morbidity. Therapeutic modalities for these diseases frequently produce adverse effects-most notably skin and nail toxicities, hand-foot syndrome (HFS; palmar-plantar erythrodysesthesia), and peripheral neuropathy-that can markedly diminish patients’ quality of life. Podiatric care is therefore critical for preventing and mitigating these sequelae. In this review, we systematically examine the foot-related complications of cancer therapy, describe their underlying pathophysiology, and delineate multidisciplinary podiatric interventions. We also highlight the benefits of close collaboration between podiatrists and oncology specialists in maintaining foot health during treatment. Finally, we summarise the specific effects of chemotherapy, radiotherapy, and immunotherapy on the feet and provide evidence-based recommendations for their management.
1 January 2025 in Revista da Associação Médica Brasileira
SUMMARY OBJECTIVE: Remnant cholesterol is an important component of triglyceride-rich lipoproteins and has emerged as an important potential biomarker for the assessment of cardiovascular risk. The aim of the study is to examine acute changes in remnant cholesterol levels pre- and post-angiography and evaluate their relationship with inflammatory markers. METHODS: A total of 183 patients who underwent coronary angiography were included in this retrospective study. Remnant cholesterol, low-density lipoprotein, high-density lipoprotein, creatine kinase-myocardial band, Troponin-T, C-reactive protein, and white blood cell levels were analyzed pre- and post-angiography. Correlation and regression analyses were used to evaluate the relationships between the data. RESULTS: Remnant cholesterol levels increased significantly post-angiography (p<0.05), while low-density lipoprotein showed no significant change (p=0.0588). C-reactive protein levels were significantly higher post-angiography than pre-angiography (p<0.05), which was considered as an indicator of procedure-related inflammatory response. Correlation analysis found a significant inverse relationship between baseline remnant cholesterol and post-angiography C-reactive protein (p0.05). Baseline remnant cholesterol (pre-angiography) levels showed an inverse association with post-procedure troponin T (β=-0.014, p0.05). CONCLUSION: This study reveals significant post-angiography increases in remnant cholesterol, indicating acute metabolic and inflammatory changes. While these findings enhance understanding of remnant cholesterol dynamics during vascular interventions, the lack of long-term outcomes necessitates cautious interpretation. Future research should validate its prognostic value and therapeutic implications. Remnant cholesterol shows potential as a biomarker but requires further investigation before clinical implementation.
14 October 2026 in Translational Biochemistry and Metabolomics
Background: The aim of this study was to investigate the apoptotic and cytotoxic effects of extracts derived from the Astragalus aduncus plant on DU-145 (human prostate cancer cells). Methods: Extracts derived from Astragalus aduncus were prepared using water, ethanol/water, ethanol, ethyl acetate, and n-hexane. Cytotoxicity in DU-145 cells was assessed using the MTT assay. The water extract that exhibited the strongest activity in the initial assessment was tested at eight different concentrations (2.5–200 µg/mL) for 24 hours, and the IC₅₀ value was determined. Cell death characteristics were examined using Annexin V/PI flow cytometry and acridine orange/ethidium bromide staining. Results: The application of the water extract caused a concentration-dependent decrease in DU-145 cell viability, and the IC₅₀ value was calculated to be 37.01 µg/mL. As a result of AO/EB staining, morphological changes characteristic of cell death-such as chromatin condensation, nuclear fragmentation, and disruption of cellular integrity-were observed. According to the flow cytometry results, the percentage of live cells decreased from 96.8% to 49.5%; the percentage of apoptotic cells increased from 2.6% to 17.6%, and the percentage of necrotic cells increased from 0.6% to 33.0%. Conclusion: It has been determined that the aqueous extract obtained from the Astragalus aduncus plant exhibits a significant cytotoxic effect on DU-145 cells and is associated with both apoptotic and necrotic cell death. However, to fully elucidate the anticancer potential of this extract, it is necessary to clarify its mechanisms of action, identify the bioactive components responsible for the observed effects, and validate the findings through mechanistic studies and in vivo models.